Recent epidemiological studies provided evidence that insulin, GH/IGF-1, and adiponectin signaling are molecular pathways interconnected with each other and linking obesity to metabolic diseases risk [54]. Here, ADIPOQ is linked to obesity due to melanocortin 4 receptor deficiency.